Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma
LPAR6 is the most recently determined G-protein-coupled receptor of the lysophosphatidic acid receptor, and very few of studies have demonstrated the performance of LPAR6 in cancers. Moreover, the relationship of LPAR6 to the potential of prognosis and tumor infiltration immune cells in different ty...
Enregistré dans:
Auteurs principaux: | Jian He, Rui Gao, Mei Meng, Miao Yu, Chengrong Liu, Jingquan Li, Yizhi Song, Hui Wang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fc06d96d8d3e47ae9e4c9e9316b94409 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
par: Guojun Lu, et autres
Publié: (2021) -
Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
par: Zhang Zhihui, et autres
Publié: (2021) -
LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma
par: Lin Z, et autres
Publié: (2021) -
LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
par: Xin Jin, et autres
Publié: (2021) -
Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
par: Maja Šutić, et autres
Publié: (2021)